Coronary artery disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.All patients who were evaluated by clinicians and were scheduled to undergo PCI surgery 2. Aged 18 to 80 years old; 3. Be able to understand the purpose of the study, voluntarily participate in this study, have the patient themselves or their legal representatives sign the informed consent form, and be willing to complete the follow-up as required by the protocol.
Exclusion criteria
Exclusion criteria: 1. QRS>130ms or placement pacemaker patients 2. Stroke within 30 days before surgery; 3. STEMI, cardiopulmonary resuscitation or cardiogenic shock within 48 hours before surgery; 4. Plan to undergo other cardiac surgery (such as aortic valve replacement, coronary artery bypass grafting, etc.) within 30 days after surgery; 5. Severe hepatic and renal insufficiency or bleeding tendency; 6. Known allergy to contrast media; 7. Severe narrowing or occlusion of blood vessels at the proposed puncture site or uncontrollable skin infection; 8. Females of childbearing age who are pregnant or lactating; 9. Other subjects who have other contraindications for interventional treatment, and other subjects who are judged by the investigator to be unsuitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiogenic death;Acute myocardial infarction;Stroke;Recurrent angina pectoris;Heart failure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Target lesion revascularizition;Coronary restenosis;Malignant arrhythmia; | — |
Countries
China
Contacts
Chengdu Third People's Hospital